ENDRA Life Sciences (NDRA) Research & Development: 2016-2021
Historic Research & Development for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to $1.4 million.
- ENDRA Life Sciences' Research & Development rose 24.43% to $1.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $5.5 million, marking a year-over-year decrease of 7.36%. This contributed to the annual value of $3.2 million for FY2024, which is 36.24% down from last year.
- Per ENDRA Life Sciences' latest filing, its Research & Development stood at $1.4 million for Q4 2021, which was up 21.26% from $1.2 million recorded in Q3 2021.
- ENDRA Life Sciences' Research & Development's 5-year high stood at $2.0 million during Q4 2019, with a 5-year trough of $95,814 in Q1 2017.
- Moreover, its 3-year median value for Research & Development was $1.5 million (2019), whereas its average is $1.5 million.
- As far as peak fluctuations go, ENDRA Life Sciences' Research & Development spiked by 1,641.73% in 2018, and later crashed by 43.63% in 2020.
- Quarterly analysis of 5 years shows ENDRA Life Sciences' Research & Development stood at $1.4 million in 2017, then decreased by 22.72% to $1.1 million in 2018, then spiked by 92.99% to $2.0 million in 2019, then slumped by 43.63% to $1.1 million in 2020, then rose by 24.43% to $1.4 million in 2021.
- Its Research & Development was $1.4 million in Q4 2021, compared to $1.2 million in Q3 2021 and $1.7 million in Q2 2021.